Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Soft Tissue Injuries D017695 2 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Leukostasis D018921 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Aoki Y et al. A simple, rapid and specific radioreceptor assay for platelet-activating factor. 1997 Adv. Exp. Med. Biol. pmid:9321990
Si Y et al. The change in plasma PAF activity before and after delivery. 1997 Adv. Exp. Med. Biol. pmid:9322006
Oh-Ishi S et al. Role of synergistic action of PAF and kinin in bacterial endotoxin-induced hypotension in rats. 1996 Adv. Exp. Med. Biol. pmid:9131154
Tetta C et al. The role of platelet-activating factor in the biocompatibility of hemodialysis membranes. 1996 Adv. Exp. Med. Biol. pmid:9131156
O'Neill C PAF promotes the development of the preimplantation embryo. 1996 Adv. Exp. Med. Biol. pmid:9131158
Ammit AJ and O'Neill C PAF released by preimplantation embryos binds to albumin. 1996 Adv. Exp. Med. Biol. pmid:9131159
Schlondorff D Interactions of platelet activating factor and prostaglandins in the glomerulus and in mesangial cells. 1989 Adv. Exp. Med. Biol. pmid:2696352
Remuzzi G Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies. 1989 Adv. Exp. Med. Biol. pmid:2696353
Bourgain RH et al. PAF-acether induced arterial thrombosis and the effect of specific antagonists. 1992 Adv. Exp. Med. Biol. pmid:1288104
Yue TL et al. Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury. 1991 Adv. Exp. Med. Biol. pmid:1667965
Söling HD et al. Regulation of protein kinases in exocrine secretory cells during agonist-induced exocytosis. 1985 Adv. Enzyme Regul. pmid:4072796
Bazan NG and Allan G Platelet-activating factor is both a modulator of synaptic function and a mediator of cerebral injury and inflammation. 1996 Adv Neurol pmid:8790822
Rubio de Krömer MT et al. Differences in eosinophil and neutrophil chemotactic responses in sowda and generalized form of onchocerciasis. 1995 Acta Trop. pmid:8546035
Konstantinov SM et al. Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. 1997 Acta Trop. pmid:9107362
Dutra PM et al. Stimulation of Leishmania tropica protein kinase CK2 activities by platelet-activating factor (PAF). 2009 Acta Trop. pmid:19433049
Zia-ul-Haq M et al. Platelet aggregation and anti-inflammatory effects of garden pea, Desi chickpea and Kabuli chickpea. 2012 Jul-Aug Acta Pol Pharm pmid:22876614
Alving K et al. The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. 1991 Acta Physiol. Scand. pmid:1957709
Arner M and Högestätt ED Endothelium-dependent relaxation and effects of prostacyclin, endothelin and platelet-activating factor in human hand veins and arteries. 1991 Acta Physiol. Scand. pmid:1715111
Björk J et al. Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds. 1983 Acta Physiol. Scand. pmid:6659994
Karlström G et al. Renal and circulatory effects of medullipin I, as studied in the in-vivo cross-circulated isolated kidney and intact Wistar-Kyoto (WKY) rat. 1989 Acta Physiol. Scand. pmid:2603751
Iversen VV et al. Platelet activating factor (PAF) increases plasma protein extravasation and induces lowering of interstitial fluid pressure (P) in rat skin. 2005 Acta Physiol. Scand. pmid:16128692
Greiff L et al. Effects of topical platelet activating factor on the guinea-pig tracheobronchial mucosa in vivo. 1997 Acta Physiol. Scand. pmid:9338520
Kecskemeti V Electrophysiological effects of platelet-activating factor (PAF) in guinea-pig cardiac preparations. 1990 Acta Physiol Hung pmid:2371852
Balogh I et al. Cytochemical effects of biologically active substances on the heart muscle. 1990 Acta Physiol Hung pmid:2371866
Penna C et al. Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor. 2009 Acta Physiol (Oxf) pmid:19432589
Lang F et al. Osmotic shock-induced suicidal death of erythrocytes. 2006 May-Jun Acta Physiol (Oxf) pmid:16734755
Saeed SA and Rasheed H Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation. 2003 Acta Pharmacol. Sin. pmid:12511226
Dahlbäck M et al. Bronchial anaphylaxis in actively sensitized Sprague Dawley rats: studies on mediators involved. 1984 Acta Pharmacol Toxicol (Copenh) pmid:6431753
Ewer AK Role of platelet-activating factor in the pathophysiology of necrotizing enterocolitis. 2002 Acta Paediatr Suppl pmid:12200892
Hsueh W et al. Platelet-activating factor, tumor necrosis factor, hypoxia and necrotizing enterocolitis. 1994 Acta Paediatr Suppl pmid:8086673
Akisü M et al. Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: is it an additional marker of perinatal asphyxia? 1998 Acta Paediatr Jpn pmid:9821700
Hüseyinov A et al. Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood. 1998 Acta Paediatr Jpn pmid:9583202
Nagakura T et al. Chemical mediators in hypersensitivity reactions. 1990 Acta Paediatr Jpn pmid:1974103
Bellioni P et al. [Histomorphological changes in nasal polyps in patients with glucose metabolism disorders]. 1988 Nov-Dec Acta Otorhinolaryngol Ital pmid:3247845
Lin J et al. Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium. 1996 Acta Otolaryngol. pmid:8820353
Terada N et al. The effect of anti-VLA-4 monoclonal antibody on eosinophil accumulation and leukotriene production in nasal mucosa. 1996 Acta Otolaryngol. pmid:8973726
Ganbo T and Hisamatsu K Mucosal dysfunction and damage induced by platelet activating factor (PAF). 1990 Nov-Dec Acta Otolaryngol. pmid:2284918
Minami T et al. Effects of various inflammatory mediators on eustachian tube patency. 1992 Acta Otolaryngol. pmid:1442015
Dolata J et al. The influence of leukotrienes and platelet activating factor on mucociliary activity in the rabbit maxillary sinus. 1990 Jan-Feb Acta Otolaryngol. pmid:2309553
Furukawa M et al. Presence of platelet-activating factor in nasal polyps and eosinophils. 2002 Acta Otolaryngol. pmid:12542208
Lin J et al. Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells. 1997 Acta Otolaryngol. pmid:9199527
Pettorossi VE and Grassi S Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2001 Acta Otolaryngol Suppl pmid:11677732
Nakano T et al. Roxythromycin reinforces epithelial defence function in rabbit trachea. 1998 Acta Otolaryngol Suppl pmid:9879427
Minami T et al. Regional blood flow volume in the eustachian tube. 1993 Acta Otolaryngol Suppl pmid:8452027
Doly M et al. Protective effect of a specific PAF antagonist on vincristine-induced experimental retinopathy. 1995 Acta Ophthalmol Scand pmid:7656145
Khan SN et al. Response to platelet-activating factor of platelets from patients with multiple sclerosis. 1985 Acta Neurol. Scand. pmid:3993327
Satoh K et al. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. 1992 Acta Neurol. Scand. pmid:1574985
Maeda T et al. Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. 1997 Acta Neurochir. Suppl. pmid:9416292
Hallenbeck JM Blood-damaged tissue interaction in experimental brain ischemia. 1994 Acta Neurochir Suppl (Wien) pmid:7976554
Tokutomi T et al. Effect of platelet-activating factor antagonist on brain injury in rats. 1994 Acta Neurochir Suppl (Wien) pmid:7976632